etigilimab,tiragolumab
roche,mereo pharmaceuticals,mereo pharmaceuticals
['tiragolumab', 'etigilimab', 'roche', 'mreo']
thefly
june 06, 2022
$mreo
08:24 messer lowered the firm's price target on mreo to $5 from $10 after the company reported "incremental" progress for etigilimab at asco but keeps a buy rating on the shares. the recent negative readouts from roche's (rhhby) tiragolumab studies
I follow Biotech Stocks